Home Product Durvalumab


IMFINZI® (durvalumab) is an immunity booster for cancer patients, a prescription medicine for lung cancer, the bladder, and urinary tract treatments. durvalumab is Sold under brand IMFINZI®

Durvalumab is classified as monoclonal antibodies and used to treat lung and a certain type of bladder and urinary tract cancer by helping patient’s immune systems fight against cancer.

Side Effects of Durvalumab(Imfinzi):

  • Tiredness.
  • Loss of appetite.
  • Nausea.
  • Constipation.
  •  Muscle/bone pain.
  • Swelling hands/ankles/feet.

If any of these effects happen or get worse, tell your doctor right away.


There are no reviews yet.

Be the first to review “Durvalumab”

Your email address will not be published. Required fields are marked *